At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 149 enrolled
Drug / intervention
citalopram hydrobromide +1 moredrug
Likely dose
citalopram hydrobromide 10mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Citalopram Treatment in Children With Autism Spectrum Disorders and High Levels of Repetitive Behavior
In Brief
A Phase 2 clinical trial evaluating citalopram hydrobromide and placebo for Autistic Disorder. Completed, enrolled 149 participants across 6 sites.
Detailed Summary
This study will determine the efficacy and safety of citalopram compared to placebo in the treatment of children with autism.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAutistic Disorder
CountriesUnited States
CollaboratorsNational Institute of Mental Health (NIMH)
Timeline
Phase 2CompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartApr 2004
First PostedJul 2004
Primary CompletionOct 2006
Study CompletionApr 2007
TodayJul 2026
First PostedJul 13, 2004
Enrollment StartApr 1, 2004
Primary CompletionOct 1, 2006
Study CompletionApr 1, 2007
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 22.0 years ago
Interventions
citalopram hydrobromidedrug
10mg/5ml solution
placeboother
up to equivalent of 20 mg of active comparator daily